Innate Pharma's IPO

Innate Pharma raised a round of funding on November 27, 2006. Investors include Public.

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or ind…

Articles about Innate Pharma's IPO: